Centro Nacional de Epidemiología-ko ikertzaileekin lankidetzan egindako argitalpenak (30)

2023

  1. Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 6, pp. 1423-1432

  2. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 20, pp. 18161-18171

  3. Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV

    HIV Medicine, Vol. 24, Núm. 6, pp. 727-737

2022

  1. Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort

    Journal of Acquired Immune Deficiency Syndromes, Vol. 90, Núm. 1, pp. 62-68

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  3. Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

    Journal of Infection

  4. Temporal Trends and Geographic Variability in the Prescription of Antiretroviral Treatments in People Living with HIV in Spain, 2004–2020

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  5. Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain

    AIDS Research and Human Retroviruses, Vol. 38, Núm. 6, pp. 433-440

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in a multicentre cohort in Spain

    Journal of the International AIDS Society, Vol. 24, Núm. 7

  3. How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

    BMC women's health, Vol. 21, Núm. 1, pp. 223

  4. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  5. Low COVID-19 mortality in Spanish children

    The Lancet Child and Adolescent Health

  6. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1678-1684

  7. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study

    BMC Infectious Diseases, Vol. 21, Núm. 1

2020

  1. Autochthonous leprosy in spain: Has the transmission of mycobacterium leprae stopped?

    PLoS Neglected Tropical Diseases, Vol. 14, Núm. 9, pp. 1-11

  2. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  3. Effectiveness and safety of antiretroviral treatment in pre- and postmenopausal women living with HIV in a multicentre cohort

    Antiviral therapy, Vol. 25, Núm. 6, pp. 335-340

  4. Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 10, pp. 3004-3014

  5. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1